PUBLISHER: IMARC | PRODUCT CODE: 1954476
PUBLISHER: IMARC | PRODUCT CODE: 1954476
The Japan laboratory automation market size reached USD 449.0 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 751.0 Million by 2034 , exhibiting a growth rate (CAGR) of 5.88% during 2026-2034 . The increased demand for high-throughput testing, rising focus on research efficiency to reduce manual workload and enhance experimental precision, rapid adoption of automation to streamline drug discovery and development processes, and deployment of robotics in clinical and pharmaceutical labs are some of the factors contributing to a steady rise in the Japan laboratory automation market share.
Pharmaceutical R&D Automation
In Japan pharmaceutical companies are increasingly adopting automation to streamline drug discovery and development processes . Automated liquid handling systems, robotic compound libraries and integrated screening platforms are now widely used to reduce manual workload and enhance experimental precision. These technologies allow researchers to conduct high-throughput screening, data analysis and sample management with minimal human intervention significantly speeding up early-stage drug development. This trend is particularly important as competition in the pharmaceutical sector intensifies and regulatory demands for accuracy increase. As automation becomes a core component of research operations the market forecast anticipates strong adoption among domestic pharma giants and biotech startups. For instance, in July 2023, Chugai Pharmaceutical unveiled its new research center, Chugai Life Science Park Yokohama. The facility emphasizes laboratory automation and AI in drug discovery featuring mobile and dual-armed robots to enhance efficiency and reduce human involvement in routine experimental tasks starting with cell culture experiments. This shift not only boosts efficiency but also reduces operational costs and human error key priorities for research-focused firms. Automation in pharmaceutical labs is expected to remain a critical driver of Japan laboratory automation market growth.
Adoption of Robotics and AI
Laboratories across Japan are increasingly deploying robotic arms, automated sample handlers, and AI-driven software to streamline workflows and minimize human error. In clinical labs, robotics is improving sample processing speed, especially in high-volume diagnostic settings. For instance, in January 2025, Japanese pharmaceutical company Daiichi Sankyo opened a state-of-the-art research lab in San Diego to enhance drug discovery using robotics and automation. This facility aims to streamline data collection and analysis, allowing scientists to focus on innovation and accelerate the development of transformative medicines for global patients. Research institutions are also integrating AI platforms to manage complex datasets, guide experimental planning, and support decision-making in real time. These technologies not only boost precision but also allow labs to handle a higher volume of tests without increasing staff. Japanese firms, backed by a strong robotics manufacturing base, are at the forefront of developing lab-specific automation systems tailored to local needs. Additionally, collaborations between tech companies and life science institutions are accelerating the deployment of AI-enabled solutions. This growing reliance on robotics and AI reflects a strategic shift toward long-term efficiency and scalability in lab operations. As this transformation continues, it is expected to strongly shape the market outlook.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.